Sponsor

Evopoint Biosciences Inc.

Clinical research sponsor

Published trials4

Recruiting shown1

Roles2

SourceClinicalTrials.gov

Clinical trials

4 shown

Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate CancerNCT06702995 · lead sponsor · 2023-04-19

RECRUITING

Study of XNW5004 Tablets in Advanced Prostate CancerNCT07730580 · lead sponsor · 2026-07-13

NOT_YET_RECRUITING

Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19)NCT06022757 · lead sponsor · 2023-09-20

TERMINATED

XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.NCT06792435 · collaborator · 2023-07-27

ACTIVE_NOT_RECRUITING

Sponsor roles

lead sponsor3

collaborator1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.